AIMS and SCOPE
Research Fields for Advances in Liquid and Molecular Oncology: Liquid Biopsy Technologies and Applications:
Liquid Biopsy Technologies and Applications:
Circulating Tumor DNA (ctDNA) detection and analysis
Circulating tumor cell (CTC) isolation and characterization
Exosome biology and clinical applications
Liquid biopsy in early cancer detection
Minimal residual disease (MRD) monitoring using liquid biopsies
Pharmacogenomics and personalized medicine with liquid biopsies
Liquid biopsy in tumor heterogeneity and evolution
Digital PCR and other novel detection methods for ctDNA
Microfluidic and lab-on-a-chip technologies for liquid biopsy
Artificial intelligence and machine learning for liquid biopsy analysis
Molecular Cancer Biology:
Tumor genomics and cancer driver mutations
Cancer epigenetics and chromatin modifications
Transcriptomics and gene expression profiling in cancer
Proteomics and protein biomarker discovery in cancer
Metabolomics and metabolic reprogramming in cancer
Non-coding RNAs and their role in cancer development
Signal transduction pathways and their therapeutic targeting
DNA repair and mechanisms of resistance to therapy
Tumor angiogenesis and vasculogenesis
Cancer stem cells and their role in tumorigenesis
Precision Oncology:
Targeted therapies and their clinical applications
Next-generation sequencing for actionable mutations
Development of novel targeted therapies and drug combinations
Pharmacodynamic and resistance mechanisms in targeted therapy
Immunotherapy and checkpoint inhibitors in cancer treatment
CAR-T cell therapy and other adoptive cell therapies
Liquid biopsy for monitoring response to therapy
Personalized medicine strategies in cancer treatment
Ethical considerations in precision oncology
Economic and healthcare implications of precision medicine
Emerging Technologies:
Artificial intelligence and machine learning in cancer diagnosis and prognosis
Big data analytics and its applications in oncology research
Deep learning algorithms for image analysis and tumor detection
Blockchain technology in healthcare and secure data sharing
CRISPR-Cas9 gene editing and its therapeutic potential
Microfluidics and organ-on-a-chip platforms for cancer research
Nano-based drug delivery systems for targeted therapy
Liquid biopsy technologies for low-resource settings
Point-of-care diagnostics for rapid cancer detection
Telemedicine and digital health in cancer care
Cancer Prevention and Early Detection:
Liquid biopsy markers for early cancer screening
Circulating biomarkers for specific cancer types
Chemoprevention strategies and risk assessment
Genetic susceptibility and predictive testing in cancer
Environmental factors and their role in cancer development
Lifestyle modifications and cancer prevention strategies
Population health approaches to cancer prevention
Public awareness and education about cancer
Ethical considerations in genetic testing and cancer risk assessment
Economic and social impact of cancer prevention strategies
Ethical and Social Implications:
Informed consent and ethical considerations in liquid biopsy research
Data privacy and security in genomic data
Equitable access to advanced cancer care and precision medicine
Disparities in cancer outcomes and addressing social determinants of health
Public policy and regulatory frameworks for genomic medicine
Psychological and social impact of cancer diagnosis and treatment
Bioethics and ethical challenges in cancer research
Patient engagement and shared decision-making in cancer care
Role of advocacy groups and patient organizations in cancer research
Addressing global cancer challenges and improving access to care
Additional Research Areas:
Tumor microenvironment and its role in cancer progression
Metabolism and metabolic dysregulation in cancer
Cancer immunology and immune evasion mechanisms
Tumor dormancy and metastasis
Cancer-associated infections and their impact on treatment
Palliative care and supportive care for cancer patients
Survivorship and long-term effects of cancer treatment
Cancer education and training for healthcare professionals
Public communication and science literacy in oncology
Role of funding agencies and philanthropic support in cancer research
Cell-free RNA and its clinical applications
Exosomal miRNA and protein cargo analysis
Liquid biopsy in brain tumors and central nervous system cancers
Circulating tumor cell functional assays and drug sensitivity testing
Non-invasive prenatal testing and cancer risk assessment
Liquid biopsy for infectious diseases and personalized antimicrobial therapy
Point-of-care liquid biopsy devices and rapid diagnostics
Standardization and harmonization of liquid biopsy assays
Liquid biopsy in clinical trials and personalized medicine implementation
Liquid biopsy for monitoring treatment response and early detection of relapse
Molecular Cancer Biology (Continued):
Non-coding DNA and regulatory elements in cancer
Long non-coding RNAs and their role in tumorigenesis
MicroRNA regulatory networks and therapeutic targets
Tumor suppressor genes and mechanisms of inactivation
Cancer cell signaling pathways and network analysis
Post-translational modifications and protein signaling in cancer
Tumor metabolism and metabolic reprogramming pathways
DNA damage repair and response mechanisms in cancer
Cancer stem cell biology and therapeutic vulnerabilities
Microenvironment interactions and tumor cell plasticity
Precision Oncology (Continued):
Pharmacogenomics and personalized dosing strategies
Liquid biopsy for guiding treatment selection and monitoring
Development of biomarkers for predicting response to immunotherapy
Overcoming treatment resistance and combination therapy approaches
Adaptive clinical trials and personalized medicine implementation
Tumor heterogeneity and clonal evolution in response to therapy
Liquid biopsy for monitoring minimal residual disease
Patient-derived organoids and personalized drug testing
Liquid biopsy in rare cancers and personalized treatment options
Cost-effectiveness analysis of precision oncology strategies
Emerging Technologies (Continued):
Single-cell sequencing and analysis in cancer research
Spatial transcriptomics and tumor microenvironment mapping
Multi-omics integration and systems biology approaches
Advanced imaging techniques for cancer diagnosis and prognosis
Nanorobots and targeted drug delivery in cancer therapy
Gene editing for therapeutic applications in cancer
Computational modeling and simulations for cancer research
Liquid biopsy platforms for personalized medicine in resource-limited settings
Blockchain technology for secure data sharing and traceability
Artificial intelligence for drug discovery and development
Cancer Prevention and Early Detection (Continued):
Circulating biomarkers for early detection of specific cancers
Liquid biopsy for personalized risk assessment and screening strategies
Cancer chemoprevention and development of novel preventive agents
Role of diet and nutrition in cancer prevention
Physical activity and lifestyle modifications for cancer risk reduction
Environmental factors and their impact on cancer incidence
Early detection programs and public health initiatives
Liquid biopsy for early detection in high-risk populations
Cancer screening disparities and addressing access to care
Psychological and behavioral factors in cancer prevention
Ethical and Social Implications (Continued):
Informed consent and patient decision-making in liquid biopsy research
Genomic data privacy and security policies
Addressing bias and discrimination in genomic testing and cancer care
Social justice and equitable access to precision medicine
Regulatory frameworks for liquid biopsy technologies and genetic testing
Addressing cultural and ethical considerations in cancer research
Public communication of risk and uncertainty in genetic testing
Role of community engagement and empowerment in cancer research
Intellectual property rights and genomic data sharing
Global ethical frameworks for cancer research and clinical trials
Additional Research Areas (Continued):
Cancer immunotherapy and novel immune checkpoint targets
Microbiome and its role in cancer development and therapy
Telomerase and telomere biology in cancer
Epigenetic therapy and targeted epigenetic modifiers
Cancer pain management and palliative care interventions
Role of complementary and alternative medicine in cancer care
Psychosocial support and interventions for cancer patients and families
Cancer survivorship and long-term effects of treatment
Workforce development and training for precision oncology specialists
Global disparities in cancer care and strategies for improvement
We at Advances in Liquid and Molecular Oncology invite you to join us on this momentous journey. Together, let us illuminate the path towards a future free from cancer, where personalized medicine reigns supreme, and hope triumphs over despair.